Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer

A genome-wide association study identifies novel risk loci for type 2 diabetes

Robert Sladek, Ghislain Rocheleau, Johan Rung et al. · Nature · 2007 · 3K citations

Life Sciences, Genetics, Molecular Genetics +14

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Leonard B. Saltz, Stephen Clarke, Eduardo Díaz‐Rubio et al. · Journal of Clinical Oncology · 2008 · 3K citations · Full text

Medicine, Oncology, Pharmacology +12

Prognosis and prognostic research: validating a prognostic model

Doug Altman, Yvonne Vergouwe, Patrick Royston et al. · BMJ · 2009 · 1.5K citations

Public Health, Biostatistics, Clinical Sciences +12

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

Jolien Tol, Miriam Koopman, Annemieke Cats et al. · New England Journal of Medicine · 2009 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +16

A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme Activity

Ilan Weisberg, Pamela V. Tran, Benedicte Christensen et al. · Molecular Genetics and Metabolism · 1998 · 1.3K citations

Life Sciences, Genetics, Molecular Genetics +11